Zuellig Pharma

Review timelines for generic drugs in the Philippines are set to be slashed dramatically, as part of efforts spearheaded by the country’s president to speed up new drug approvals and bring down medici

When Chris Cargill became president and CEO of Sosei Heptares in March 2022, high on his initial to-do list were a number of items around the transition of the Japan-UK company to the next stage of

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Brii, Qpex Partner To Bring

Diversified market expansion services group DKSH may be based in Switzerland but conducts the bulk of its business in Asia, with a presence across consumer goods, performance materials, and technology